Phase I trial of OTS11101, an anti-angiogenic vaccine targeting vascular endothelial growth factor receptor 1 in solid tumor

Novel Strategies in Therapy of Head and Neck Cancer

(2011) R. Mehrotra et al.   CURRENT CANCER DRUG TARGETS

Predictive Value of Intratumoral Microvascular Density in Patients with Advanced Non-small Cell Lung Cancer Receiving Chemotherapy Plus Bevacizumab

(2011) Yuan-Yuan Zhao et al.   Journal of Thoracic Oncology

Plasma concentrations of VCAM-1 and PAI-1: A predictive biomarker for post-operative recurrence in colorectal cancer

(2010) Yasuhide Yamada et al.   CANCER SCIENCE

Predictive and prognostic angiogenic markers in a gynecologic oncology group phase II trial of bevacizumab in recurrent and persistent ovarian or peritoneal cancer

(2010) Ernest S. Han et al.   GYNECOLOGIC ONCOLOGY

High Levels of Circulating VEGFR2+ Bone Marrow-Derived Progenitor Cells Correlate with Metastatic Disease in Patients with Pediatric Solid Malignancies

(2009) M. Taylor et al.   CLINICAL CANCER RESEARCH

Efficacy, Safety, and Potential Biomarkers of Sunitinib Monotherapy in Advanced Hepatocellular Carcinoma: A Phase II Study

(2009) Andrew X. Zhu et al.   JOURNAL OF CLINICAL ONCOLOGY

Biomarkers of response and resistance to antiangiogenic therapy

(2009) Rakesh K. Jain et al.   Nature Reviews Clinical Oncology

Vascular Endothelial Growth Factor Expression in Invasive Papillary Thyroid Carcinoma

(2009) Vergilius José Furtado de Araujo-Filho et al.   THYROID

Clinical biomarkers of angiogenesis inhibition

(2008) Aaron P. Brown et al.   CANCER AND METASTASIS REVIEWS

Vascular Endothelial Growth Factor Mediated Decrease in Plasma Soluble Vascular Endothelial Growth Factor Receptor-2 Levels as a Surrogate Biomarker for Tumor Growth

(2008) J. M.L. Ebos et al.   CANCER RESEARCH

Identification of prognostic biomarkers in gastric cancer using endoscopic biopsy samples

(2008) Yasuhide Yamada et al.   CANCER SCIENCE

New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)

(2008) E.A. Eisenhauer et al.   EUROPEAN JOURNAL OF CANCER

Multiple roles for CD4+T cells in anti-tumor immune responses

(2008) Richard Kennedy et al.   IMMUNOLOGICAL REVIEWS

Phase II Study of Sunitinib Malate, an Oral Multitargeted Tyrosine Kinase Inhibitor, in Patients With Metastatic Breast Cancer Previously Treated With an Anthracycline and a Taxane

(2008) Harold J. Burstein et al.   JOURNAL OF CLINICAL ONCOLOGY